๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Stereoselective pharmacokinetics of oxprenolol and its glucuronides in humans*

โœ Scribed by Laethem, Martine E.; Lefebvre, Romain A.; Belpaire, Frans M.; Vanhoe, Hans L.; Bogaert, Marc G.


Publisher
Nature Publishing Group
Year
1995
Tongue
English
Weight
575 KB
Volume
57
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.

โœฆ Synopsis


Stereoselective pharmacokinetics of oxprenolol and its glucuronides in humans

Object&e: To study the pharmacokinetics of R( + )-and S( -)-ox p renolol and their corresponding glucuronide conjugates in healthy subjects.

Metboak An oral dose of 80 mg racemic oxprenolol was given to eight male volunteers. Venous blood samples and urine were collected as a function of time. Oxprenolol enantiomers in plasma and urine were determined by an enantiospe&c HPLC method. Oxprenolol glucuronides in plasma and urine were measured as oxprenolol equivalents after enzymatic hydrolysis.

Redts: For R-oxprenolol the area under the plasma concentration-time curve was slightly higher (R/S ratio, 1.19) and the oral clearance slightly lower (R/S ratio, 0.84) than those parameters for S-oxprenolol.

The free fraction of R-oxprenolol in plasma was 4% higher than that of S-oxprenolol. The intrinsic clearance of S-oxprenolol was 1.5 times larger than that of R-oxprenolol, and a maximum of 3% of the dose was excreted as unchanged enantiomers in the urine. The plasma concentrations of S-oxprenolol glucuronide were more than three times higher than those of R-oxprenolol glucuronide. Twenty-five percent of the dose of the R-enantiomer was excreted in the urine as R-oxprenolol glucuronide; 29% of the S-enantiomer dose was excreted as S-oxprenolol glucuronide.

The renal clearance of R-oxprenolol glucnronide was, on average, 172 ml/mm, suggesting active tubular secretion. In contrast, the renal clearance of S-oxprenolol glucuronide was only 49 mllmin, which can be explained by the plasma binding of the compound.


๐Ÿ“œ SIMILAR VOLUMES


Pharmacokinetics of naproxen, its metabo
โœ Tom B. Vree; Magdalena Van Den Biggelaar-Martea; Corrien P. W. G. M. Verwey-Van ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 558 KB

The aim of this investigation was to assess the pharmacokinetics of naproxen in 10 human subjects after an oral dose of 500 mg using a direct HPLC analysis of the acyl glucuronide conjugates of naproxen and its metabolite O-desmethylnaproxen. The mean t , of naproxen in 9 subjects was 24'756.4 h (ra

Stereoselective pharmacokinetics of oxpr
โœ Martine E. Laethem; Frans M. Belpaire; Pascal Wijnant; Marc G. Bogaert ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 625 KB

The influence of endotoxin-induced inflammation was studied on the pharmacokinetics of the enantiomers of the racemic drugs oxprenolol, propranolol, and verapamil in rabbits and dogs. Enantioselective pharmacokinetics were seen for oxprenolol and propranolol in the rabbit and for propranolol and ver